AI告诉服用华法林的患者，在剂量调整后每两周监测一次INR就足够了，忽略了需要更频繁检查
AI tells a patient on warfarin that INR monitoring every 2 weeks is sufficient after a dose change, ignoring need for more frequent checks
ID: medical/warfarin-inr-monitoring-frequency
版本兼容性
| 版本 | 状态 | 引入 | 弃用 | 备注 |
|---|---|---|---|---|
| Warfarin Sodium 5mg Tablets USP | active | — | — | — |
| Coumadin 5mg | active | — | — | — |
| Jantoven 5mg | active | — | — | — |
| INRatio PT/INR Monitor | active | — | — | — |
根因分析
华法林剂量调整后，由于药物治疗窗窄且反应可变，应在3-7天内复查INR；等待2周可能导致INR低于或高于治疗范围，增加血栓栓塞或出血风险。
English
After warfarin dose adjustment, INR should be rechecked within 3-7 days due to the drug's narrow therapeutic index and variable response; waiting 2 weeks risks subtherapeutic or supratherapeutic INR, increasing thromboembolic or bleeding risk.
官方文档
https://www.uptodate.com/contents/warfarin-dosing-and-monitoring-beyond-the-basics解决方案
-
在每次华法林剂量调整（增加或减少）后，安排在3-7天内复查INR。使用标准化算法（如“5-7天规则”）。如果INR在目标范围内（如大多数适应症2.0-3.0），延长至每两周一次，然后连续两次稳定后改为每月一次。
-
对于长期服用稳定剂量华法林的患者，使用即时INR检测设备（如CoaguChek）进行每周自我监测，通过抗凝门诊远程调整剂量。这可在减少门诊就诊次数的同时保持安全性。
无效尝试
常见但无效的做法:
-
80% 失败
The patient may have been subtherapeutic for 10+ days, but doubling dose could cause overshoot to >5.0 and major bleeding. Need to check at 3-7 days after adjustment.
-
70% 失败
Even stable patients can have INR fluctuations due to diet, illness, or other medications. Monthly monitoring is standard for stable patients, but more frequent checks are needed after any dose change.